Huntsman Corporation ($HUN) Stock Falling In pre-market As Markets React To Merger of Equals...
Pre-market activity has Huntsman Corporation (NYSE: HUN) dropping 8.8 percent after revealing merger agreement with Olin .Olin Corporation and Huntsman Corporation have announced a...
Elicio Therapeutics, Inc. ($ELTX) shares are sliding ahead of the open
Elicio Therapeutics, Inc. (NASDAQ: ELTX) is seeing its shares edging lower 49.9 percent in pre-market trading after Phase 2 study misses endpoint.The company ...
What’s happening with Soleno Therapeutics, Inc. ($SLNO) shares surging in early trading?
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is trending higher in pre-market trading as markets react to Neurocrine's acquisition deal.
Neurocrine Biosciences has announced an agreement to...
What’s driving Cyclerion Therapeutics, Inc. ($CYCN) shares dropping 19% in early trading?
Investors are pushing Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) lower in pre-market trading, with shares moving lower 19.28 percent after announcing Cyclerion and Korsana merger...
China Natural Resources, Inc. ($CHNR) shares are climbing ahead of the open
China Natural Resources, Inc. (NASDAQ: CHNR) stock is moving higher 58 percent in pre-market trading amid news of acquisition.The company has signed a non-binding...
Solo Brands, Inc. ($SBDS) shares are sliding 27 percent before the bell
Solo Brands, Inc. (NYSE: SBDS) stock is declining 27 percent in pre-market trading in response to weaker fourth 2025 results.The company reported a weaker...
SailPoint, Inc. ($SAIL) shares down 12% pre-market on Fourth Quarter Results
SailPoint, Inc. (NASDAQ: SAIL) is trading lower in pre-market trading as markets react to its fourth quarter results and forward guidance.
The company reported its...
LENSAR, Inc. ($LNSR) shares down 25% in pre-market trading after Termination Of Merger Agreement
LENSAR, Inc. (NASDAQ: LNSR) is plunging in pre-market trading, with shares down 25 percent following the termination of the merger agreement with Alcon Research.
LENSAR,...
Aldeyra Therapeutics, Inc. ($ALDX) shares tumbling 74% in early trading following the Receipt of...
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) stock is plummeting 74 percent in pre-market trading subsequent to FDA issues Complete Response Letter.
Aldeyra Therapeutics has received a...
Nasus Pharma Ltd. ($NSRX) shares falling 9% in pre-market on Reporting Positive Phase 2...
Shares of Nasus Pharma Ltd. (NYSE: NSRX) are trading down 9.03 percent ahead of the open after disclosing Positive Phase 2 results for NS002.
Nasus...